Licensed Peptides
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Licensed Peptides between 25 Mar 2026 and 4 Aug 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Licensed Peptides
Retatrutide
Tested 4 Samples
Last test 4 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Licensed Peptides
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
4 Aug 2026
First
25 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 4 Aug 2026 | View | 15mg | (no batch claim) | 12.6mg | -16.0% | 99.90% | low | RETATR-01 | White Label / Black Crimp / Clear Cap | Lab E | Public | |
| 8 Jun 2026 | View | 5mg | (no batch claim) | 5.3mg | +6.0% | 99.50% | n/a | GLP3R1229 | White label / Silver crimp / Blue cap | Lab G | Public | |
| 26 Apr 2026 | View | 5mg | 5.8mg | 3.42mg | -40.7% | 99.40% | below LOQ | GLP3R1229 | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 25 Mar 2026 | View | 5mg | (no batch claim) | 5.3mg | +6.0% | 99.20% | n/a | RETATB-01 | White Label / Silver Crimp / Blue Cap | Lab G | Public | |